Literature DB >> 19766344

The incidence of type 2 diabetes mellitus in the Philippines: a 9-year cohort study.

Maria Luz B Soria1, Rody G Sy, Bernard S Vega, Tommy Ty-Willing, Angela Abenir-Gallardo, Felicidad Velandria, Felix Eduardo Punzalan.   

Abstract

AIMS: Currently, there are no available data on the incidence of type 2 diabetes mellitus (T2DM) in the Philippines. A cohort derived from a national study population (FNRI-NNS, 1998) was revisited after 9 years to yield valuable data on glucose homeostasis among Filipinos.
METHODS: Six out of 13 national regions were included in the cohort. There were 1749 out of 2122 respondents (82.4%). 1386 (95.9%) consented to a fasting blood glucose (FBG) test, and 1275 (88.2%) completed the 2h post-glucose (2HPG) load determination using whole blood capillary samples.
RESULTS: We observed a significant increase of mean FBGs (91.5mg/dL to 103.3mg/dL) from 1998 to 2007. The 9-year incidence of T2DM was 16.3%. The prevalence of T2DM was 28.0%. The prevalence of pre-diabetes, i.e., combined impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) was 31.3%; IFG was 17.5% and IGT was 23.9%.
CONCLUSIONS: The study shows the alarming growth of diabetes, IFG, and IGT in our country that warrants early aggressive intervention for prevention and management. We encourage the use of 2h post-glucose load aside from FBG in screening for true diabetics, IFGs, and IGTs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19766344     DOI: 10.1016/j.diabres.2009.07.014

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  21 in total

1.  Diabetes risk in older Mexican Americans: effects of language acculturation, generation and socioeconomic status.

Authors:  Aimee Afable-Munsuz; Steven E Gregorich; Kyriakos S Markides; Eliseo J Pérez-Stable
Journal:  J Cross Cult Gerontol       Date:  2013-09

2.  Polymorphisms in fatty acid binding protein 5 show association with type 2 diabetes.

Authors:  Liming Bu; Lorena M Salto; Kevin J De Leon; Marino De Leon
Journal:  Diabetes Res Clin Pract       Date:  2011-02-01       Impact factor: 5.602

3.  Fourth Asian PAD Workshop.

Authors: 
Journal:  Ann Vasc Dis       Date:  2013

4.  Evidence based review of type 2 diabetes prevention and management in low and middle income countries.

Authors:  Aimee Afable; Nidhi Shree Karingula
Journal:  World J Diabetes       Date:  2016-05-25

5.  Prevalence of metabolic syndrome among Filipino-Americans: a cross-sectional study.

Authors:  Alona Dalusung-Angosta; Antonio Gutierrez
Journal:  Appl Nurs Res       Date:  2013-07-29       Impact factor: 2.257

6.  Duration of US Residence and Obesity Risk in NYC Chinese Immigrants.

Authors:  Aimee Afable; Ming-Chin Yeh; Tushar Trivedi; Erin Andrews; Judith Wylie-Rosett
Journal:  J Immigr Minor Health       Date:  2016-06

7.  [Immigrant generation and diabetes risk among Mexican Americans: the Sacramento Area Latino Study on Aging].

Authors:  Aimee Afable-Munsuz; Elizabeth Rose Mayeda; Eliseo J Pérez-Stable; Mary N Haan
Journal:  Rev Panam Salud Publica       Date:  2013-08

8.  Immigrant generation and diabetes risk among Mexican Americans: the Sacramento Area Latino Study on Aging.

Authors:  Aimee Afable-Munsuz; Elizabeth Rose Mayeda; Eliseo J Pérez-Stable; Mary N Haan
Journal:  Am J Public Health       Date:  2013-03-14       Impact factor: 9.308

9.  Immigrant generation and diabetes risk among Mexican Americans: the Sacramento area Latino study on aging.

Authors:  Aimee Afable-Munsuz; Elizabeth Rose Mayeda; Eliseo J Pérez-Stable; Mary N Haan
Journal:  Am J Public Health       Date:  2014-04       Impact factor: 9.308

10.  Association of central adiposity with prediabetes and decreased insulin sensitivity in rural Chinese normal-weight and overweight women.

Authors:  Yunxian Yu; Scott A Venners; Binyan Wang; Wendy J Brickman; Donald Zimmerman; Zhiping Li; Liuliu Wang; Xue Liu; Genfu Tang; Houxun Xing; Xiping Xu; Xiaobin Wang
Journal:  Metabolism       Date:  2010-01-04       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.